Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$79.48M$79.48Mderived+1.0% vs Q4 2012 Net Income$28.41M$28.41Mderived+4.3% vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$59,117,000+0.4% Operating Incomederived-$118,494,531N/M Operating Cash Flowderived$29,987,000−19.8% Free Cash Flowderived$24,641,000−32.1% Margins · derivedGross margin74.4%−0.4 pt vs Q4 2012
Operating margin-149.1%−201.5 pt vs Q4 2012
Net margin35.7%+1.1 pt vs Q4 2012
ended Jun 30, 2013 · filed Aug 29, 2013 · 60 d after period end